Based on the
information you provided, we found the following studies.
A Phase 2, Open-label, Single-arm Study of Niraparib in Women with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer who have Received at Least Three Previous Chemotherapy RegimensYou may have screening exams or tests done to find our if you are eligible to participate.This study is researching all of the following topics:Fallopian tube cancerOvarian cancerPPC, Primary peritoneal cancer
This study is looking for:
Volunteers with specific conditions